Regeneron will reduce prices for its drugs on Medicaid. A cholesterol drug, Praluent, will be available for USD 225 on Trump's discounted d...

Novartis introduces a financing scheme with Pine Labs for its cholesterol-lowering drug, Sybrava (inclisiran), in India, aiming to broaden ...

The company in an exchange notification said that it has entered into a three-year deferred prosecution agreement, and if the company adher...

Similarly, the price of Paracetamol and Caffeine has been fixed at Rs 2.88 per tablet. Besides, the price of one Rosuvastatin Aspirin and C...

The Justice Department has been investigating allegations the company colluded with other drugmakers to push up the prices of widely used p...

The lawsuit widens a complaint of price collusion filed in 2016, which is still pending in US courts after being first investigated in 2014.

While National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 20 formulations, it has also capped the ceiling prices of...

The development follows a price revision as per annual Wholesale Price Index (WPI) at the rate of 3.44 percent increase, the National Pharm...

Drug price regulator has also asked manufacturers to furnish quarterly return regarding production, import and sale of their products.

Ranbaxy Laboratories today said it has launched generic versions of Atorvastatin tablets, used for treating cholesterol, in Italy, Sweden a...

Watson’s launch raises questions on India’s third-largest drug company Ranbaxy Laboratories’ revenues from the drug.

Shares of Ranbaxy climbed over 5 per cent in trade on Thursday on reports that the company will release a generic version Lipitor in the US...

AstraZeneca India announced the launch of CRESTOR® (rosuvastatin) 5, 10, 20 and 40 mg tablets. CRESTOR® is indicated for use in the treatme...

Ranbaxy has settled most of its patent disputes with Pfizer, allowing it to launch a generic version of Lipitor from November 30, 2011. Ran...

Ranbaxy Laboratories’ third quarter net profit surged nearly seven times, but its share price declined after the results were announced.

Pfizer on Thursday said third-quarter earnings doubled from the year-ago quarter when it took a big merger-related charge, helped by strong...

Wal-Mart on Thursday said it would slash prices on nearly 300 generic prescription drugs to $4 starting in Tampa, Florida and plans to expa...